Human pancreatic cancer cell line AsPC-1 harbors KRAS mutation, p53 mutation and wild-type EGFR, thus representing a malignant phenotype commonly observed in pancreatic cancers (17). This evidence concerns the gene KRAS and familial pancreatic carcinoma.